Skip to content

Opening book details…

About this Medicine article

Neoadjuvant capecitabine (X), docetaxel (T)±trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): preliminary safety and efficacy data from a multicentre phase II study by W. Lybaert; Wildiers; P. Neven; P. Clement; M.R. Christiaens; C. Weltens; R. Drijkoningen; C. Van Ongeval; A. Van Steen; R. Paridaens is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
W. Lybaert; Wildiers; P. Neven; P. Clement; M.R. Christiaens; C. Weltens; R. Drijkoningen; C. Van Ongeval; A. Van Steen; R. Paridaens
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 1359-6349)
Published
2006
Field
Medicine (Health Sciences)

More by W. Lybaert; Wildiers; P. Neven; P. Clement; M.R. Christiaens; C. Weltens; R. Drijkoningen; C. Van Ongeval; A. Van Steen; R. Paridaens

Browse all works by W. Lybaert; Wildiers; P. Neven; P. Clement; M.R. Christiaens; C. Weltens; R. Drijkoningen; C. Van Ongeval; A. Van Steen; R. Paridaens